Company profilePharmaceutical#997 of 1,318 in Pakistan✓ No DRAP alerts

Remedies International

Pharmaceutical company · 4 brands · 3 molecules

Ranked #37 of 74 companies in Pain Management

4 registered products 3 pharmaceutical brands 3 distinct molecules 0 DRAP alerts

Company overview

4
registered products
3
pharmaceutical brands
3
distinct molecules
3
therapeutic classes
0
DRAP alerts

Remedies International is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 4 product registrations across 3 distinct molecules. Its portfolio is concentrated in Pain Management and Gastro. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Remedies

4 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Fever/Flu/Cough 1

Top molecules by brand count

Omeprazole1 brand
Ketorolac Trometamol Inj1 brand

Therapeutic classes

Pain Management · 2Gastro · 1Fever/Flu/Cough · 1

Conditions treated

Topical · 1Ulcer/Reflux/Flatulence/Acidity · 1Pain Killers · 1Cold/Cough/Flu · 1

Price band (DRAP official ceilings)

Registered products priced by source
Servaid4 products · Rs 98.9 – Rs 345
Median across source: Rs 232.5

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Next Pharmaceutical Products (Pvt.) Ltd holds 47 molecules not in this portfolio
AmlodipineAprepitantArginineArtemetherAtorvastatinAtorvastatin Calcium
AGP (PRIVATE) LTD. holds 141 molecules not in this portfolio
AmikacinAminophyllineAmlodipineAmoxicillinAprepitantArtemether
HIGHNOON LABORATORIES LIMITED holds 163 molecules not in this portfolio
000 I.U5-Fluorouracil 500MgAceclofenacAcyclovirAcyclovir Inf/OralAmlodipine

Get the full profile for Remedies

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.